The findings from the CBL-0204 Phase 2b clinical trial have been selected for presentation at IMCAS, the premier global congress in aesthetic medicine. The data will be highlighted in both the 2025 ...
LONDON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced its participation in the 2025 International ...
HONG KONG, Feb. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global wellness group ...
BEIJING, Feb. 2, 2024 /PRNewswire/ -- In the morning of February 1st, Wingderm® announced the launch of Lasermach2 at IMCAS World Congress 2024 in Paris, which represents another revolutionizing ...
Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative biostimulation, HA and neuromodulator treatments at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results